Mark October 27 on Your Calendar
Because on that day...You'll have the chance to win prizes worth up to $10,000...AND get a free ticker symbol of a stock that's experienced 1,400% year-over-year net income growth.
Click here now to reserve your seat.
pixel
A.J. Kazimi, insider at Cumberland Pharmaceuticals
A.J. Kazimi Insider Alerts

Get notified the next time A.J. Kazimi buys or sells Cumberland Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

A.J. Kazimi Insider Information

Mr. Kazimi founded our company in 1999 and has served as the Chairman of our Board of Directors and Chief Executive Officer since inception. His career includes 30 years in the biopharmaceutical industry. At Cumberland, he has overseen the development and FDA approval of the company’s Acetadote® and Caldolor® brands, while also leading the acquisition of the Company’s five other commercial products. He was responsible for Cumberland’s initial public offering and listing on the NASDAQ stock exchange. He also serves as Chairman and Chief Executive of Cumberland Emerging Technologies. Prior to joining our company, he spent eleven years helping to build Therapeutic Antibodies Inc., an international biopharmaceutical company.

As President and Chief Operating Officer, he made key contributions to that company’s growth from its start-up phase through its initial public offering and listing on the London stock exchange. Mr. Kazimi started his career at Brown-Forman Corporation, rising through a series of management positions and helping to launch several new products. Mr. Kazimi serves on the Board of Directors for the Nashville Health Care Council, an association of the largest concentration of healthcare companies in the U.S. He also serves on the Boards of the Tennessee Historical Society and the Gettysburg Foundation which partners with the National Park Service to preserve the historic military park.

Mr. Kazimi is a member of the Board of Visitors at the Vanderbilt University Business School and the Visiting Committee at the Loyola University New Orleans’ College of Business. He previously served on the board of Aegis Sciences Corporation, a federally certified forensic toxicology laboratory, which has sold twice to large private equity investors. He holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt University Owen Graduate School of Management. 

What is A.J. Kazimi's net worth?

The estimated net worth of A.J. Kazimi is at least $15.46 million as of July 1st, 2021. Mr. Kazimi owns 5,768,184 shares of Cumberland Pharmaceuticals stock worth more than $15,458,733 as of October 24th. This net worth approximation does not reflect any other investments that Mr. Kazimi may own. Learn More.

How do I contact A.J. Kazimi?

The corporate mailing address for Mr. Kazimi and other Cumberland Pharmaceuticals executives is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. Cumberland Pharmaceuticals can also be reached via phone at (615) 255-0068 and via email at [email protected]

Has A.J. Kazimi been buying or selling shares of Cumberland Pharmaceuticals?

A.J. Kazimi has not been actively trading shares of Cumberland Pharmaceuticals over the course of the past ninety days. Most recently, on Wednesday, September 29th, A J. Kazimi bought 15 shares of Cumberland Pharmaceuticals stock. The stock was acquired at an average cost of $2.82 per share, with a total value of $42.30.

Who are Cumberland Pharmaceuticals' active insiders?

Cumberland Pharmaceuticals' insider roster includes Martin Cearnal (SVP), Joseph Galante (Director), A. J. Kazimi (CEO), A.J. Kazimi (CEO), Kenneth Krogulski (Director), and William Sumas (EVP).

Are insiders buying or selling shares of Cumberland Pharmaceuticals?

In the last twelve months, Cumberland Pharmaceuticals insiders bought shares 135 times. They purchased a total of 19,024 shares worth mmore than $55,054.28. In the last twelve months, insiders at the specialty pharmaceutical company sold shares 1 times. They sold a total of 1,830 shares worth mmore than $42,986.70. The most recent insider tranaction occured on September, 29th when Joseph C Galante Director bought 142 shares worth more than $400.44. Insiders at Cumberland Pharmaceuticals own 41.2 % of the company.

Information on this page was last updated on 9/29/2021.

A.J. Kazimi Insider Trading History at Cumberland Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/29/2021Buy15$2.82$42.30View SEC Filing Icon  
9/27/2021Buy15$2.79$41.85View SEC Filing Icon  
9/24/2021Buy15$2.74$41.10View SEC Filing Icon  
9/22/2021Buy15$2.76$41.40View SEC Filing Icon  
9/20/2021Buy15$2.82$42.30View SEC Filing Icon  
9/17/2021Buy15$2.85$42.75View SEC Filing Icon  
9/15/2021Buy15$2.86$42.90View SEC Filing Icon  
9/13/2021Buy15$2.96$44.40View SEC Filing Icon  
9/9/2021Buy15$2.77$41.55View SEC Filing Icon  
9/7/2021Buy15$2.79$41.85View SEC Filing Icon  
9/3/2021Buy15$2.85$42.75View SEC Filing Icon  
9/1/2021Buy15$2.88$43.20View SEC Filing Icon  
8/30/2021Buy15$2.88$43.205,768,844View SEC Filing Icon  
8/25/2021Buy15$2.79$41.85View SEC Filing Icon  
8/23/2021Buy15$2.87$43.055,768,844View SEC Filing Icon  
8/20/2021Buy15$2.96$44.40View SEC Filing Icon  
8/18/2021Buy15$2.97$44.55View SEC Filing Icon  
8/16/2021Buy15$2.92$43.805,768,844View SEC Filing Icon  
8/9/2021Buy15$2.93$43.955,768,844View SEC Filing Icon  
8/4/2021Buy15$3.18$47.70View SEC Filing Icon  
8/2/2021Buy15$3.34$50.10View SEC Filing Icon  
7/29/2021Buy15$3.42$51.30View SEC Filing Icon  
7/26/2021Buy15$3.41$51.15View SEC Filing Icon  
7/23/2021Buy15$3.35$50.255,768,529View SEC Filing Icon  
7/12/2021Buy15$3.33$49.95View SEC Filing Icon  
7/6/2021Buy15$3.14$47.105,768,529View SEC Filing Icon  
7/1/2021Buy15$2.91$43.655,768,184View SEC Filing Icon  
6/28/2021Buy15$3.16$47.405,768,184View SEC Filing Icon  
6/25/2021Buy15$3.09$46.355,768,184View SEC Filing Icon  
6/23/2021Buy15$3.07$46.055,768,184View SEC Filing Icon  
6/21/2021Buy15$3.14$47.10View SEC Filing Icon  
6/16/2021Buy15$3.09$46.35View SEC Filing Icon  
6/14/2021Buy15$3.09$46.355,768,184View SEC Filing Icon  
6/11/2021Buy15$3.18$47.705,768,184View SEC Filing Icon  
6/9/2021Buy15$3.14$47.10View SEC Filing Icon  
5/28/2021Buy15$2.93$43.95View SEC Filing Icon  
5/26/2021Buy15$2.85$42.755,767,734View SEC Filing Icon  
5/21/2021Buy15$3.06$45.905,767,734View SEC Filing Icon  
5/19/2021Buy15$2.83$42.45View SEC Filing Icon  
5/17/2021Buy15$2.84$42.605,767,734View SEC Filing Icon  
5/14/2021Buy15$2.81$42.15View SEC Filing Icon  
5/12/2021Buy15$2.86$42.905,767,734View SEC Filing Icon  
5/10/2021Buy15$2.71$40.65View SEC Filing Icon  
5/7/2021Buy15$2.73$40.95View SEC Filing Icon  
5/3/2021Buy15$2.66$39.905,767,734View SEC Filing Icon  
4/30/2021Buy15$2.78$41.705,767,734View SEC Filing Icon  
4/28/2021Buy15$2.94$44.10View SEC Filing Icon  
4/26/2021Buy15$2.97$44.555,767,734View SEC Filing Icon  
4/23/2021Buy15$2.99$44.85View SEC Filing Icon  
4/19/2021Buy15$3.04$45.605,767,734View SEC Filing Icon  
4/16/2021Buy15$3.03$45.455,767,734View SEC Filing Icon  
10/18/2019Buy34$5.45$185.305,766,502View SEC Filing Icon  
10/16/2019Buy60$5.56$333.605,766,502View SEC Filing Icon  
10/14/2019Buy60$5.67$340.205,766,502View SEC Filing Icon  
10/11/2019Buy60$5.71$342.605,766,502View SEC Filing Icon  
10/9/2019Buy60$5.78$346.805,766,502View SEC Filing Icon  
10/7/2019Buy60$5.74$344.405,766,502View SEC Filing Icon  
10/4/2019Buy60$5.76$345.605,766,502View SEC Filing Icon  
10/2/2019Buy60$5.77$346.205,766,502View SEC Filing Icon  
9/30/2019Buy60$5.89$353.405,766,502View SEC Filing Icon  
9/27/2019Buy60$5.76$345.605,766,502View SEC Filing Icon  
9/25/2019Buy60$5.38$322.805,766,502View SEC Filing Icon  
9/23/2019Buy60$5.35$321.005,766,502View SEC Filing Icon  
9/20/2019Buy60$5.33$319.805,766,502View SEC Filing Icon  
9/18/2019Buy120$4.93$591.605,764,222View SEC Filing Icon  
9/16/2019Buy60$4.97$298.205,764,222View SEC Filing Icon  
9/13/2019Buy120$5.18$621.605,764,222View SEC Filing Icon  
9/11/2019Buy60$5.02$301.205,764,222View SEC Filing Icon  
9/9/2019Buy60$5.19$311.405,764,222View SEC Filing Icon  
9/6/2019Buy120$4.91$589.205,764,222View SEC Filing Icon  
9/4/2019Buy60$4.79$287.405,764,222View SEC Filing Icon  
8/29/2019Buy120$5.04$604.805,764,222View SEC Filing Icon  
8/27/2019Buy120$5.19$622.805,764,222View SEC Filing Icon  
8/23/2019Buy60$5.38$322.805,764,222View SEC Filing Icon  
8/21/2019Buy60$5.49$329.405,764,222View SEC Filing Icon  
8/19/2019Buy60$5.51$330.605,764,222View SEC Filing Icon  
8/16/2019Buy120$5.62$674.405,764,222View SEC Filing Icon  
8/14/2019Buy60$5.49$329.405,764,222View SEC Filing Icon  
8/12/2019Buy60$5.91$354.605,764,222View SEC Filing Icon  
8/9/2019Buy120$6.02$722.405,764,222View SEC Filing Icon  
8/7/2019Buy60$6.07$364.205,764,222View SEC Filing Icon  
8/5/2019Buy60$6.17$370.205,764,222View SEC Filing Icon  
8/2/2019Buy120$6.15$738.005,764,222View SEC Filing Icon  
7/31/2019Buy60$5.94$356.405,764,222View SEC Filing Icon  
7/29/2019Buy60$5.87$352.205,764,222View SEC Filing Icon  
7/26/2019Buy60$5.86$351.605,764,222View SEC Filing Icon  
7/24/2019Buy60$5.93$355.805,762,542View SEC Filing Icon  
7/22/2019Buy60$5.75$345.005,762,542View SEC Filing Icon  
7/19/2019Buy60$5.69$341.405,762,542View SEC Filing Icon  
7/17/2019Buy60$5.85$351.005,762,542View SEC Filing Icon  
7/15/2019Buy60$5.85$351.005,762,542View SEC Filing Icon  
7/12/2019Buy60$6.01$360.605,762,542View SEC Filing Icon  
7/10/2019Buy60$6.07$364.205,762,542View SEC Filing Icon  
7/8/2019Buy60$6.37$382.205,762,542View SEC Filing Icon  
7/5/2019Buy60$6.49$389.405,762,542View SEC Filing Icon  
7/3/2019Buy60$6.46$387.605,762,542View SEC Filing Icon  
7/1/2019Buy60$6.52$391.205,762,542View SEC Filing Icon  
6/28/2019Buy60$6.49$389.405,762,542View SEC Filing Icon  
6/26/2019Buy60$6.54$392.405,762,542View SEC Filing Icon  
6/24/2019Buy60$6.54$392.405,762,542View SEC Filing Icon  
6/21/2019Buy60$6.34$380.405,762,542View SEC Filing Icon  
6/19/2019Buy60$6.35$381.005,762,542View SEC Filing Icon  
6/17/2019Buy60$6.33$379.805,762,542View SEC Filing Icon  
6/14/2019Buy60$6.37$382.205,762,542View SEC Filing Icon  
6/12/2019Buy60$6.29$377.405,760,899View SEC Filing Icon  
6/10/2019Buy60$6.09$365.405,760,899View SEC Filing Icon  
6/7/2019Buy60$6.07$364.205,760,899View SEC Filing Icon  
6/5/2019Buy50$6.67$333.505,760,899View SEC Filing Icon  
6/3/2019Buy60$6.49$389.405,760,899View SEC Filing Icon  
5/30/2019Buy60$6.58$394.805,760,899View SEC Filing Icon  
5/28/2019Buy60$6.65$399.005,760,899View SEC Filing Icon  
5/24/2019Buy60$6.67$400.205,760,899View SEC Filing Icon  
5/22/2019Buy60$6.58$394.805,760,899View SEC Filing Icon  
5/20/2019Buy60$6.89$413.405,760,899View SEC Filing Icon  
5/17/2019Buy106$6.25$662.505,760,899View SEC Filing Icon  
5/14/2019Buy36$5.62$202.325,760,899View SEC Filing Icon  
5/10/2019Buy57$6.01$342.575,760,899View SEC Filing Icon  
5/8/2019Buy58$6.35$368.305,760,899View SEC Filing Icon  
5/6/2019Buy42$6.29$264.185,760,899View SEC Filing Icon  
5/2/2019Buy73$5.61$409.535,760,899View SEC Filing Icon  
4/30/2019Buy27$6.37$171.995,760,899View SEC Filing Icon  
4/26/2019Buy14$6.32$88.485,760,899View SEC Filing Icon  
4/24/2019Buy32$6.04$193.285,760,899View SEC Filing Icon  
4/17/2019Buy81$6.21$503.015,760,899View SEC Filing Icon  
4/12/2019Buy99$6.32$625.685,760,899View SEC Filing Icon  
4/9/2019Buy1,526$6.13$9,354.385,759,656View SEC Filing Icon  
4/5/2019Buy183$6.32$1,156.565,759,656View SEC Filing Icon  
4/2/2019Buy580$6.12$3,549.605,759,656View SEC Filing Icon  
See Full Table

A.J. Kazimi Buying and Selling Activity at Cumberland Pharmaceuticals

This chart shows A J Kazimi's buying and selling at Cumberland Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cumberland Pharmaceuticals Company Overview

Cumberland Pharmaceuticals logo
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.
Read More

Today's Range

Now: $2.68
Low: $2.62
High: $2.68

50 Day Range

MA: $2.80
Low: $2.66
High: $3.10

2 Week Range

Now: $2.68
Low: $2.58
High: $3.94

Volume

12,102 shs

Average Volume

39,410 shs

Market Capitalization

$39.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.2
FREE DOWNLOAD: Simple Options Trading For Beginners
Avoid the account-crippling mistakes most rookies make with options trading...

...by using the simple steps to safely and profitably growing your account revealed in this free report.

(It's a quick read.)
Click to download.
pixel